Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tepidimicrobium xylanilyticum

ABSTRACT: Tepidimicrobium xylanilyticum Whole Genome Sequencing Project

PROVIDER: PRJDB15770 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	DRR462745_1.fastq.gz	Fastqsanger.gz
	DRR462745_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Microbacterium xylanilyticum JCM 13591

Project description:Genome sequencing of Microbacterium xylanilyticum JCM 13591

| PRJDB932 | ENA

Luteimicrobium xylanilyticum strain:HY-24

Project description:Luteimicrobium xylanilyticum strain:HY-24 Genome sequencing

| PRJNA579204 | ENA

Tepidimicrobium xylanilyticum DSM 23310

Project description:Tepidimicrobium xylanilyticum DSM 23310

| PRJNA262328 | ENA

Petroclostridium xylanilyticum strain:SK-Y3

Project description:Petroclostridium xylanilyticum strain:SK-Y3 Genome sequencing and assembly

| PRJNA396427 | ENA

E-MTAB-5200

Project description:The International Cancer Genome project: Pan-Cancer Analysis of Whole Genomes (PCAWG)

2025-01-23 | E-MTAB-5200 | ExpressionAtlas

Tepidimicrobium xylanilyticum strain:GN1

Project description:Characterization of a novel, xylanolytic, anaerobic, thermophilic bacterium Tepidimicrobium xylanilyticum GN1

| PRJDB9862 | ENA

E-MTAB-5423

Project description:The International Cancer Genome project: Pan-Cancer Analysis of Whole Genomes (PCAWG)- Alternative view by individual

2025-01-23 | E-MTAB-5423 | ExpressionAtlas

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Whole genome SNP array data from myelodysplastic syndromes (MDS) patients

Project description:With the whole genome SNP array information obtained from tumor and matched normal control, we could evaluate the acquired copy number variations (CNVs) and uniparental disomies (UPDs) . Seven MDS patients in a whole genome sequencing project were included in this experiment.

2014-05-22 | GSE57229 | GEO

E-MTAB-8633

Project description:RNA-seq samples of ten tissues for each of the 25 genomes of the Nested Associated Mapping (NAM) maize sequencing project

2024-11-17 | E-MTAB-8633 | ExpressionAtlas